Arterial thrombosis is frequently the proximate cause of death and morbidity in cardiovascular diseases, the leading cause of death in the Western World. The applicants propose to continue an interdisciplinary training program for post-doctoral scientists in the areas of blood cells in hemostasis, thrombosis, and vascular biology to be a centerpiece in an Initiative in Vascular Biology at the University of California San Diego, La Joll Campus. Most faculty members are internationally recognized investigator in the development and functioning of blood and vascular cells or in bioinformatic and biophysical tools applied to the study of such cells. Each faculty member has a strong track record of peer-reviewed research support and senior faculty has extensive track records in post-doctoral training. The faculty has interacted extensively through the mechanisms of collaboration and through program projects focused on Vascular Biology and Hemostasis-thrombosis. The interdisciplinary nature of the program is established by the faculty primary appointments in Multiple University Departments including, Cellular and Molecular Medicine (JDE,DT), Biology (DT,JYW), pathology (DC), Physics (AG), Pharmacology (TR), and Medicine (SJS, JAV, TI, TR, JYW, &MHG). The core of the program will be through performance of research in faculty laboratories spanning the disciplines of signal transduction, gene regulation, hematopoiesis, angiogenesis, and the molecular and cell biology of cells of the blood and vessel wall. This training program will provide a unique interdisciplinary educational opportunity to mentor outstanding scientists for research careers in the cellular basis of hemostasis, thrombosis, and vascular biology and will form the only active training program at UCSD directly devoted to this health-related field.
Arterial thrombosis is frequently the proximate cause of death and morbidity in cardiovascular diseases, the leading cause of death in the Western World. This interdisciplinary training program will prepare both M.D. and Ph.D. scientists for careers in both basic and translational research into these diseases.
|Lagarrigue, Frederic; Gingras, Alexandre R; Paul, David S et al. (2018) Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation. Blood Adv 2:2358-2368|
|Tong, Wenyong; Dwyer, Chrissa A; Thacker, Bryan E et al. (2017) Guanidinylated Neomycin Conjugation Enhances Intranasal Enzyme Replacement in the Brain. Mol Ther 25:2743-2752|
|Dwyer, Chrissa A; Scudder, Samantha L; Lin, Ying et al. (2017) Neurodevelopmental Changes in Excitatory Synaptic Structure and Function in the Cerebral Cortex of Sanfilippo Syndrome IIIA Mice. Sci Rep 7:46576|
|Shi, Eileen; Chmielecki, Juliann; Tang, Chih-Min et al. (2016) FGFR1 and NTRK3 actionable alterations in ""Wild-Type"" gastrointestinal stromal tumors. J Transl Med 14:339|
|Yeang, Calvin; Hung, Ming-Yow; Byun, Young-Sup et al. (2016) Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a). J Clin Lipidol 10:594-603|
|Bajaj, Jeevisha; Konuma, Takaaki; Lytle, Nikki K et al. (2016) CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia. Cancer Cell 30:792-805|
|Tavori, Hagai; Christian, Devon; Minnier, Jessica et al. (2016) PCSK9 Association With Lipoprotein(a). Circ Res 119:29-35|
|Dwyer, Chrissa A; Esko, Jeffrey D (2016) Glycan susceptibility factors in autism spectrum disorders. Mol Aspects Med 51:104-14|
|Singh, Alok R; Joshi, Shweta; Burgoyne, Adam M et al. (2016) Single Agent and Synergistic Activity of the ""First-in-Class"" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma. Mol Cancer Ther 15:2553-2562|
|Yeang, Calvin; Tsimikas, Sotirios (2016) The role of lipoprotein(a) in progression of renal disease: Causality or reverse causality? J Diabetes Complications 30:755-7|
Showing the most recent 10 out of 30 publications